These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 35132672)

  • 1. Persistence of Ad26.COV2.S-associated vaccine-induced immune thrombotic thrombocytopenia (VITT) and specific detection of VITT antibodies.
    Kanack AJ; Singh B; George G; Gundabolu K; Koepsell SA; Abou-Ismail MY; Moser KA; Smock KJ; Green D; Major A; Chan CW; Wool GD; Reding M; Ashrani AA; Bayas A; Grill DE; Padmanabhan A
    Am J Hematol; 2022 May; 97(5):519-526. PubMed ID: 35132672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biophysical studies do not reveal direct interactions between human PF4 and Ad26.COV2.S vaccine.
    van der Neut Kolfschoten M; Inganäs H; Perez-Peinado C; Calado da Silva Freire J; Melchers JM; van Dijk N; Przeradzka M; Kourkouta E; van Manen D; Vellinga J; Custers J; Bos R
    J Thromb Haemost; 2024 Apr; 22(4):1046-1055. PubMed ID: 38159648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential mechanisms of vaccine-induced thrombosis.
    Marietta M; Coluccio V; Luppi M
    Eur J Intern Med; 2022 Nov; 105():1-7. PubMed ID: 35953336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole Blood Procoagulant Platelet Flow Cytometry Protocol for Heparin-Induced Thrombocytopenia (HIT) and Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Testing.
    Lee CSM; Powell MC; Chen VM
    Methods Mol Biol; 2023; 2663():441-461. PubMed ID: 37204729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective review COVID-19 vaccine induced thrombotic thrombocytopenia and cerebral venous thrombosis-what can we learn from the immune response.
    Franceschi AM; Petrover DR; McMahon TM; Libman RB; Giliberto L; Clouston SAP; Castillo M; Kirsch C
    Clin Imaging; 2022 Oct; 90():63-70. PubMed ID: 35926315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple Electrode Aggregometry (Multiplate): Functional Assay for Vaccine-Induced (Immune) Thrombotic Thrombocytopenia (VITT).
    Kong Y; Kershaw G; Fu YKS; Passam F
    Methods Mol Biol; 2023; 2663():429-440. PubMed ID: 37204728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low clinical utility of testing for anti-platelet factor 4 in asymptomatic individuals after ChAdOx1 nCoV-19 vaccine.
    Barefah AS; Radhwi OO; Alamri SS; Alahwal HM; Denetiu I; Almohammadi AT; Bahashwan SM; Qari MH; Algaissi A; Alamer E; Alhazmi A; Abuzenadah AM; Nasraldeen WH; Alzahrani SH; Hashem AM
    Int J Lab Hematol; 2022 Apr; 44(2):424-429. PubMed ID: 34850575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Uncommon thrombotic complications after SARS-CoV-2 vaccination].
    Musil D
    Vnitr Lek; 2021; 67(5):297-302. PubMed ID: 35459396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of vaccine-induced immune thrombotic thrombocytopenia (VITT).
    Greinacher A; Schönborn L; Siegerist F; Steil L; Palankar R; Handtke S; Reder A; Thiele T; Aurich K; Methling K; Lalk M; Völker U; Endlich N
    Semin Hematol; 2022 Apr; 59(2):97-107. PubMed ID: 35512907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-PF4 positivity and platelet activation after Ad26.COV2·S vaccination in Brazil.
    Bokel J; Martins-Gonçalves R; Grinsztejn E; Mendes-de-Almeida DP; Hoagland B; Cardoso SW; Geraldo KM; Coutinho SN; Georg I; Oliveira MH; Dos Santos Souza F; Sacramento CQ; Rozini SV; Vizzoni AG; Veloso V; Bozza PT; Grinsztejn B
    Vaccine; 2024 Nov; 42(25):126175. PubMed ID: 39107160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Most anti-PF4 antibodies in vaccine-induced immune thrombotic thrombocytopenia are transient.
    Schönborn L; Thiele T; Kaderali L; Günther A; Hoffmann T; Seck SE; Selleng K; Greinacher A
    Blood; 2022 Mar; 139(12):1903-1907. PubMed ID: 35113987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Off-the-shelf cryopreserved platelets for the detection of HIT and VITT antibodies.
    Kanack AJ; Jones CG; Singh B; Leger RR; Splinter NP; Heikal NM; Pruthi RK; Chen D; George G; Abou-Ismail MY; Wool GD; Gundabolu K; Padmanabhan A
    Blood; 2022 Dec; 140(25):2722-2729. PubMed ID: 35998675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-PF4 VITT antibodies are oligoclonal and variably inhibited by heparin.
    Singh B; Kanack A; Bayas A; George G; Abou-Ismail MY; Kohlhagen M; Christ M; Naumann M; Moser K; Smock K; Grazioli A; Murray D; Padmanabhan A
    medRxiv; 2021 Sep; ():. PubMed ID: 34611669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal vaccine-induced immune thrombotic thrombocytopenia (VITT) post Ad26.COV2.S: first documented case outside US.
    Rodriguez EVC; Bouazza FZ; Dauby N; Mullier F; d'Otreppe S; Jissendi Tchofo P; Bartiaux M; Sirjacques C; Roman A; Hermans C; Cliquennois M
    Infection; 2022 Apr; 50(2):531-536. PubMed ID: 34626338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal Aspects of VITT.
    Schönborn L; Greinacher A
    Semin Hematol; 2022 Apr; 59(2):108-114. PubMed ID: 35512899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Platelet-Activating Antibodies Associated with Vaccine-Induced Thrombotic Thrombocytopenia by Flow Cytometry: An Italian Experience.
    Cesari F; Sorrentino S; Gori AM; Rogolino A; De Cristofaro R; Giusti B; Sticchi E; De Candia E; Marcucci R
    Viruses; 2022 May; 14(6):. PubMed ID: 35746602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine-induced immune thrombotic thrombocytopenia after COVID-19 vaccination: Description of a series of 39 cases in Brazil.
    Mouta Nunes de Oliveira P; Mendes-de-Almeida DP; Bertollo Gomes Porto V; Crespo Cordeiro C; Vitiello Teixeira G; Saraiva Pedro R; Roberto Gomes Takey P; Kegele Lignani L; Reis Xavier J; Cardoso Doria da Gama V; Amorim Filho L; Emoingt Furtado B; Santa Maria A; Dahrug Barros T; Neves Waite Freitas L; Dos Santos Pereira T; Lima Abreu D; Bernardes Ramos M; Gabe C; Arnold D; William Smith J; Nazy I; Lourdes de Sousa Maia M;
    Vaccine; 2022 Aug; 40(33):4788-4795. PubMed ID: 35779962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombotic anti-PF4 immune disorders: HIT, VITT, and beyond.
    Greinacher A; Warkentin TE
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):1-10. PubMed ID: 38066843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of laboratory assays for anti-platelet factor 4 antibodies after ChAdOx1 nCOV-19 vaccination.
    Platton S; Bartlett A; MacCallum P; Makris M; McDonald V; Singh D; Scully M; Pavord S
    J Thromb Haemost; 2021 Aug; 19(8):2007-2013. PubMed ID: 33973336
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.